Andrew K. Solow | People | Arnold & Porter

Andrew Solow’s practice focuses on life sciences product liability and complex commercial litigation. Andrew has extensive experience serving as national counsel, trial counsel, and settlement counsel for leading pharmaceutical companies in a wide range of mass tort and product liability litigations involving both prescription and over-the-counter products.

Andrew has also represented both plaintiffs and defendants in civil litigations in courts across the United States involving commercial, contract, fraud, antitrust, securities, foreign currency trading, trademark, patent, intellectual properly, and civil RICO claims.

He also counsels domestic and international corporations, individual clients, charitable trusts, and private equity funds on overall litigation and trial strategy, strategic settlement decisions, and litigation avoidance.

Prior to joining the firm in 1999, Andrew clerked for The Honorable Charles L. Brieant, in the United States District Court, Southern District of New York. During his time at the firm, Andrew completed a secondment as in-house counsel for a global pharmaceutical company. As a result of his tenure as in-house counsel, he has a real-world understanding of the in-house corporate legal function, and substantial experience counseling corporate executives and employees on a variety of legal and commercial issues.

Focus Areas

Experience

Monsanto and Bayer as national counsel in defense of their nationwide litigation involving Roundup®.
International pharmaceutical company as settlement counsel in an MDL and coordinated state court proceedings involving personal injuries for RX and OTC medications.
Bayer Corporation and Bayer HealthCare Pharmaceuticals Inc. as national counsel in defense of their prescription antibiotic medications Cipro® and Avelox® in product liability litigation, including an MDL.
Bayer Corporation and Bayer HealthCare Pharmaceuticals Inc. as national coordinating counsel in the defense of their oral anticoagulant prescription medication, Xarelto® in product liability litigation, including an MDL.
Major pharmaceutical company as co-lead national counsel and trial counsel in a series of cases (including those combined within an MDL) brought by government prosecutors, third-party payors, and private individuals alleging fraudulent marketing and improper distribution of opioids for chronic pain and seeking billions in abatement costs, damages, restitution, and civil penalties.

Major pharmaceutical company as national counsel and trial counsel in product liability litigation, including an MDL, involving TRT (Testosterone Replacement Therapy) products defending against claims of heart attack, stroke, and related cardiac issues.
Pfizer as co-national counsel in product liability lawsuits alleging birth defects related to the antidepressant Zoloft®.
Pfizer and Wyeth Pharmaceuticals Inc. as co-national counsel in product liability lawsuits alleging birth defects related to the antidepressant Effexor XR®, including dismissal of all cases pending in the MDL.
Pfizer, Pharmacia & Upjohn Co., and Wyeth Pharmaceuticals Inc., as trial counsel and national counsel in the Hormone Therapy Litigation responsible for all aspects of litigation, including trial preparation and trial, global strategy, settlement and mediations, and management and coordination of regional and local counsel. Notable trial victories include the following:
- In May 2012, Andrew, along with Pamela J. Yates (partner in the Los Angeles office), served as co-lead trial counsel for Pfizer units Wyeth Inc. and Wyeth Pharmaceuticals in U.S. District Court (Connecticut) and obtained a defense verdict on all counts related to a wrongful death suit involving Wyeth's hormone therapy (HT) medications Premarin and Prempro. After a three-week trial, the jury dismissed all four of the alleged claims. This decision marks Andrew and Pamela's second win in less than one year regarding both HT medications. Lynn Gardner Moss, et al. v. Wyeth Inc., et al.
- In July 2011, Andrew, along with Pamela, served as trial counsel for Pfizer units Wyeth Pharmaceuticals Inc. and Pharmacia & Upjohn Co. and obtained a defense verdict in a case involving claims of injuries from the client's HT medicines. After a three-week trial, the jury found that the HT prescription medicines did not cause the plaintiff's breast cancer and that the plaintiff's claims were time-barred by the applicable statute of limitations. Notably, this is the first HT defense verdict for Pharmacia & Upjohn. Hines v. Wyeth, et al.
AstraZeneca in thousands of product liability lawsuits alleging that its atypical antipsychotic drug, Seroquel, causes diabetes and related injuries. Andrew assisted in the strategic end game/settlement analysis that contributed to the successful resolution of the litigation.
Novartis Consumer Health Inc. in connection with plaintiffs who claimed injuries from over-the-counter products containing PPA. In his role as national coordinating counsel, Andrew was responsible for management and coordination of regional and local counsel, as well as strategy and discovery in the coordinated New York proceedings.
Major Pharmaceutical Company as co-lead national counsel in a series of cases (including those combined within an MDL) brought by government prosecutors, third-party payors, and private individuals alleging fraudulent marketing and improper distribution of opioids for chronic pain and seeking billions in abatement costs, damages, restitution, and civil penalties.